Epstein-Barr Virus (EBV)

Description

All three antibodies in this combination recognize distinct epitopes in the hydrophilic carboxyl region of the latent membrane protein (LMP) protein encoded by the Epstein Barr Virus antibody (EBV). EBV has been implicated with Hodgkin’s disease, and may be involved in the pathogenesis of Hodgkin’s occurring in children. Other studies have shown a low incidence of EBV in B-cell type lymphomas unless patients were immunologically impaired, such as post-organ transplantation or autoimmune type diseases. Studies have shown that this antibody does stain EBV + Burkitt’s lymphomas but has shown some cross reactivity with smooth muscle and blood vessels.

SPECIFICATIONS

Specifications

WEIGHT N/A
DIMENSIONS N/A
INTENDED USE ASR
SPECIES REACTIVITY Human
SOURCE Mouse Monoclonal
CLONE EBV01, 02, and 03
ISOTYPE IgG1 /kappa
ANTIGEN Epstein-Barr Virus (EBV) protein
LOCALIZATION Membrane or paranuclear
POSITIVE CONTROL EBV infected Hodgkin’s
OUS ONLY IVD

 

REFERENCES

1. Queiroga EM, et al. Am J Clin Pathol. 2008 Aug; 130(2):186-92.
2. Prochorec-Sobieszek M, et al. Pol J Pathol. 2006; 57(2):63-70.
3. Montes-Moreno S, et al. Mod Pathol. 2012 Jul; 25(7):968-82.

Reviews

There are no reviews yet.

Be the first to review “Epstein-Barr Virus (EBV)”

Your email address will not be published. Required fields are marked *